Um flavonol inédito, 4'-metoxikaempferol-7-(acetiloxi)-3,5-O--L-ramnosídeo (1), três flavonóides conhecidos, apigenina, 7-O-metoxiquercetrina e quercetrina e quatro triterpenos, -amirina, -amirina, ácido oleanólico e ácido ursólico foram isolados das folhas de Chiococca braquiata. As estruturas dessas substâncias foram elucidadas com base em seus dados espectroscópicos.
Introduction
The genus Chiococca (Rubiaceae) with 22 species is endemic of the American Continent, and occurs from North America to Brazil. Several Chiococca species have been traditionally used in these regions for the treatment of numerous human ailments including inflammation, antivirus, anti-edema and as aphrodisiac. 1 Other plants belonging to the Rubiaceae family have yielded a number of interesting biologically active compounds, 2, 3 including seco-iridoids with mild DNA-activity isolated from Chiococca alba. 4 C. braquiata, however, has not been subjected to phytochemical analysis or assayed for any biological activity. In an ongoing quest to identify biologically active compounds from the Brazilian Rubiaceae plant species, antifungal evaluation using Cladosporium sphaerospermum and C. cladosporioides was performed on CH 2 Cl 2 -MeOH (2:1, v/v) extract from C. braquiata leaves, which exhibited strong antifungal activity. Bioassay-guided fractionation of the bioactive extract led to the isolation of the inactive flavonoids 4'-methoxykaempferol-7-(acetyloxy)-3,5-O--L-rhamnoside (1), apigenin, 7-O-methoxyquercetrin and quercetrin. The triterpenes -amirin, -amirin, ursolic and oleanolic acids were also isolated. The structure of the new derivative 1 and the known compounds were elucidated by spectroscopic methods, mainly 2D NMR and MS.
Experimental

General procedures
For column chromatography silica gel 60 (Merck 230-400 mesh) and Sephadex LH-20 were used. TLC analysis carried out on silica gel 60 F 254 . IR spectrum was recorded on a Nicolet Spectrometer. UV spectra were recorded on a Perkin-Elmer UV/Vis Spectrometer Lambda 14P. The ES-MS spectra were obtained on a VG Platform II Spectrometer. NMR spectra were recorded in DMSO-d 6 
Bioassay
The antifungal activity against C. cladosporioides was performed using direct bioautography with 10 L of the solutions of crude extracts and pure compounds, which were prepared in different concentrations ranging from 300 to 10 g respectively, as described elsewhere. 5 
Extraction and isolation of compounds
Air-dried powdered leaves (2.0 kg) were extracted with CH 2 Cl 2 -MeOH (2:1) at room temperature. The CH 2 Cl 2 -MeOH extract was evaporated in vacuum to give a crude extract (120 g), which was partitioned into equal volumes of MeO-H 2 O (80%) and hexane (3x). The hydromethanolic extract was concentrated to 60% and was subsequently extracted using CHCl 3 (3x) and EtOAc (3x). These were evaporated to give a hexane phase (5 g), a chloroform phase (12 g), an ethyl acetate phase (4.7 g) and a hydromethanolic phase (42 g).
The ethyl acetate phase was applied to a column of Sephadex LH-20 (30 g) eluted with MeOH-H 2 O with increasing polarity to give 17 fractions. Fraction 8 (123 mg) was applied again to a column of Sephadex LH-20 (5 g) eluted with MeOH to give 6 fractions. The sub-fractions 8.2 and 8.3 yielded mixture of triterpenes -amirin andamirin (39 mg) and ursolic and oleanolic acids (64 mg), respectively. Fractions 11 and 12 were combined (176 mg) and further purified by reverse phase preparative thin-layer chromatography in MeOH-H 2 O (8.5:1.5) leading to the isolation of 4'-methoxykaempferol-7-(acetyloxy)-3,5-O--L-rhamnoside (1; 21 mg). Fraction 13 (460 mg) was applied to a silica gel column (230-400 mesh) eluted with ethyl acetate containing increasing concentration of methanol (up to 100%) to give apigenin (2; 174 mg). Fraction 14/15 (111 mg) was applied to a column of Sephadex LH-20 (2 g) eluted with MeOH to give 7-Omethoxyquercetrin (3; 60 mg). Fractions 16/17 (175 mg), after recristalization in acetone, gave quercetrin (4; 165 mg). 
4'-Methoxykaempferol-7-(acetyloxy)-3,5-O-a-Lrhamnoside (1).
Results and Discussion
The bioactive soluble EtOAc part of a CH 2 Cl 2 :MeOH (2:1, v/v) extract, prepared from the leaves of C. braquiata, was chromatographed over Sephadex LH-20 column and preparative TLC to afford a new flavonoid 1, along with the know compounds apigenin (2), 6 7-O-methoxyquercetrin (3), 7 quercetrin (4), 8 -amirin, -amirin, ursolic and oleanolic acids. C NMR spectra (Table 1) (Table 1) confirmed these positions as glycosylation sites due to the connectivities that were observed between 5.30 (1H, br s, H-1") and 134.2 (C-3) and the correlation between 5.30 (1H, br s, H-1"') and 161.7 (C-5). The correlation between the signal corresponding to -OCH 3 at 3.79 with C-4' at d 161.7 also was important to attribute all substitutions in 1, if we consider that the only remain place linkage for the acetyl group should be at hydroxyl group in C-7. In fact, by the NOESY experiments ( Figure 1 ) was observed a weak spatial correlation between the signal at 6.89 (H-3' and/or H-5' with the resonance at 3.79 corresponding to -OMe. The absence of cross peaks correlation between H-6 and H-8 with the CO of the acetyl group could suggested that this group was not attached to the hydroxyl at C-7. However, a correlation observed in the HMBC spectrum (Table 1) between the anomeric hydrogens at 5.30 and C-5 (161.7) and C-3 (134.2) indicated that the second sugar unit was located at C-3, and thus corroborated the acetylation site at C-7. These findings confirmed the substitution pattern for compound 1. The absence of a bathochromic shift in the UV (methanol) spectrum after the addition of AlCl 3 was other important evidence for the substitution of the 5-OH, as well as the substitution at C-7 being indicated by the absence of a bathochromic shift in band II (ring A) upon addition of NaOAc. To our knowledge, 1 is a new flavonol derivative assigned as 4'-methoxykaempferol-7-(acetyloxy)-3,5-O--L-rhamnoside (1).
The strong antifungal activity detected in the crude extract (minimum amount required for the inhibition of fungal growth on TLC plates = 10 g for C.
cladosporioides, standard nystatin = 1.0 g) was decreased proportionally during fractionation procedures. The detection limit values of the CHCl 3 , and EtOAc bioactive solubles (50 and 30 g, respectively) suggested that the antifungal activity was substantially lost during guidedfractionating of the EtOAc extract with fungus C. cladosporioides. The very weak activity detected for pure flavonols 1-4 (detection limit values higher than 300 g) indicated that their individual activities are not potent enough to be considered for practical use or to justify the strong activity detected in the crude extract. The antifungal activity against C. cladosporioides was significantly enhanced when a combination of the flavonols 1, 2, 3 and 4 where tested. The detection limit of compound 1 against C. cladosporioides was reduced from 350 to 100 g when it was combined with compounds 2 (300), 3 (400), and 4 (250). Based on these observations, the synergistic activity of these compounds, and probably of others not isolated in this study, against this fungus, could be inferred.
